Replies to post #55540 on Anavex Life Sciences Corp (AVXL)

[circa1762]

Maybe so -- still doubt that represents most retail investors. I didn't have a ton of company on Anavex message boards back in 2012-2014, but there was a large number of retail investors that got in during the first half of 2015 before the stock started its big run. Even $14.83 or whatever will look great eventually if the science confirms the early signals in this present trial.

[2014turnaround]

No one on this board bought there!

[XenaLives]

This simply isn't true -the insane volume came afterward. If someone did buy at the high they are either out or have averaged down.

$14.83,high volume was huge many bought there or a little lower. Many in the red.

The VBP gaps in the chart below show that the run up was not organic, it was fake.



Yes, quite a few bought at the top I'm sure but one the way up it was also heavily wash traded and it was immediately shorted. As you can see below, heavy distribution continued until December. Yes one of the insties sold 4 million, but IMO that was probably not done on the open market. Whoever it was orchestrating the pump, I hope the SEC finds them out.

Because of the nature of the company's drug there is huge interest in this stock, people who buy in become emotionally invested in the success of Anavex and this probably disrupts the algos. Note that on the chart above the stock was trading pretty flat in the $4.50- $4.80 area (split adjusted). Note also that the median was $7.52 and the September low was $3.57. I'm sure these numbers are familiar.

See the chart below - the serious volume started on the last down day. I think that there is a NSS bagholder here who has been working very hard to shake out people like myself who got in on the volatility and stayed in because of the science and the potential of unprecedented market valuation for their CNS pipeline.

Next week will be very interesting.